THE STORY OF MEDICINAL GENOMICS & CANNMED
Behind every company, lies a story of purpose. For Medicinal Genomics, their commitment to cannabis science and education is rooted in family, and a passion for helping others. Founded by Kevin McKernan, MGC developed trailblazing technologies to prioritize cannabis safety through genetics, which the McKernan's used to help combat their father's stage-4 prostate cancer. With guidance from industry leaders Dr. Raphael Mechoulam, Dr. Bonni Goldstein, Dr. Dustin Sulak, Dr. Debra Kimless, and Mara Gordon, the McKernans were able to maximize his quality of life, to the awe of many doctors and nurses overseeing his care. This challenging experience led MGC to create CannMed Events, a yearly event to prioritize cannabis science, innovation, and collaboration - to advance the industry and improve patient care. The McKernan story is highlighted in the March/April 2021 issue of Cannabis Patient Care.
Special thanks to Cannabis Science and Technology for documenting this journey. Their quarterly publication, Cannabis Patient Care, addresses one cannabis topic through a variety of focus perspectives: doctor, patient, nurse, research, advocacy, and caregiver. Please consider supporting their important work with a read, a share, and a follow on social media @cannabispatientcare
ATTENDANCE IS LIMITED. THE OPPORTUNITIES ARE NOT.
